The anxiolytic effect of probiotics: A systematic review and meta-analysis of the clinical and preclinical literature

PLoS ONE

Volumn 13, Issue 6, 2018, Pages

  Reis, Daniel J ^a   Ilardi, Stephen S ^a   Punt, Stephanie E W ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT; ANXIOLYTIC AGENT;

ANIMAL BEHAVIOR; ANXIETY DISORDER; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS; BIFIDOBACTERIUM PSEUDOCATENULATUM; CLINICAL RESEARCH; CLOSTRIDIUM BUTYRICUM; DRUG EFFECT; ENTEROCOCCUS FAECIUM; HUMAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS HELVETICUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; META ANALYSIS; MYCOBACTERIUM VACCAE; NONHUMAN; PEDIOCOCCUS ACIDILACTICI; PRECLINICAL STUDY; REVIEW; STREPTOCOCCUS THERMOPHILUS; SYSTEMATIC REVIEW; THERAPY EFFECT; TRANQUILIZING ACTIVITY; ANIMAL; ANXIETY; EXPLORATORY BEHAVIOR; FEMALE; MALE; MAZE TEST; METHODOLOGY; MOUSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RAT; SPECIES DIFFERENCE;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; ANXIETY DISORDERS; DRUG EVALUATION, PRECLINICAL; EXPLORATORY BEHAVIOR; FEMALE; HUMANS; LACTOBACILLUS RHAMNOSUS; MALE; MAZE LEARNING; MICE; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RATS; RESEARCH DESIGN; SPECIES SPECIFICITY;

EID: 85048870387     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0199041     Document Type: Review

References (100)

1. Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J, et al. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc. 2009; 18(1): 23–33. Epub 2009/04/22. PMID: 19378696; PubMed Central PMCID: PMCPMC3039289.
2. Baxter AJ, Vos T, Scott KM, Ferrari AJ, Whiteford HA. The global burden of anxiety disorders in 2010. Psychol Med. 2014; 44(11): 2363–74. Epub 2014/01/24. https://doi.org/10.1017/ S0033291713003243 PMID: 24451993.
3. Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010; 56(1): 38–46. Epub 2010/07/14. https://doi.org/10.1016/j.jacc.2010.03.034 PMID: 20620715.
4. Cox RC, Olatunji BO. A systematic review of sleep disturbance in anxiety and related disorders. J Anxiety Disord. 2016; 37: 104–29. Epub 2016/01/09. https://doi.org/10.1016/j.janxdis.2015.12.001 PMID: 26745517.
5. Lai HM, Cleary M, Sitharthan T, Hunt GE. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug Alcohol Depend. 2015; 154: 1–13. Epub 2015/06/15. https://doi.org/10.1016/j.drugalcdep.2015.05.031PMID: 26072219.
6. Bandelow B, Reitt M, Rover C, Michaelis S, Gorlich Y, Wedekind D. Efficacy of treatments for anxiety disorders: A meta-analysis. Int Clin Psychopharmacol. 2015; 30(4): 183–92. Epub 2015/05/02. https://doi.org/10.1097/YIC.0000000000000078 PMID: 25932596.
7. Loerinc AG, Meuret AE, Twohig MP, Rosenfield D, Bluett EJ, Craske MG. Response rates for CBT for anxiety disorders: Need for standardized criteria. Clin Psychol Rev. 2015; 42: 72–82. Epub 2015/09/ 01. https://doi.org/10.1016/j.cpr.2015.08.004 PMID: 26319194.
8. Baldwin D, Woods R, Lawson R, Taylor D. Efficacy of drug treatments for generalised anxiety disorder: Systematic review and meta-analysis. BMJ. 2011; 342: d1199. Epub 2011/03/15. https://doi.org/10.1136/bmj.d1199 PMID: 21398351.
9. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005; 307(5717): 1915–20. Epub 2005/03/26. https://doi.org/10.1126/science. 1104816 PMID: 15790844.
10. Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems. Annals of Gastroenterology. 2015; 28(2): 203–9. PubMed PMID: WOS:000359016600007. PMID: 25830558
11. de Vos WM, de Vos EA. Role of the intestinal microbiome in health and disease: From correlation to causation. Nutr Rev. 2012; 70 Suppl 1: S45–56. Epub 2012/08/17. https://doi.org/10.1111/j.17534887.2012.00505.x PMID: 22861807.
12. Walter SA, Jones MP, Talley NJ, Kjellstrom L, Nyhlin H, Andreasson AN, et al. Abdominal pain is associated with anxiety and depression scores in a sample of the general adult population with no signs of organic gastrointestinal disease. Neurogastroenterol Motil. 2013; 25(9): 741–e576. Epub 2013/05/23. https://doi.org/10.1111/nmo.12155 PMID: 23692044.
13. Fond G, Loundou A, Hamdani N, Boukouaci W, Dargel A, Oliveira J, et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): A systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. 2014; 264(8): 651–60. Epub 2014/04/08. https://doi.org/10.1007/s00406-014-0502-z PMID: 24705634.
14. Neuendorf R, Harding A, Stello N, Hanes D, Wahbeh H. Depression and anxiety in patients with Inflammatory Bowel Disease: A systematic review. J Psychosom Res. 2016; 87: 70–80. Epub 2016/ 07/15. https://doi.org/10.1016/j.jpsychores.2016.06.001 PMID: 27411754.
15. Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. Isme j. 2007; 1(1): 56–66. Epub 2007/11/29. https://doi.org/10.1038/ismej.2007.3 PMID: 18043614.
16. Lurie I, Yang YX, Haynes K, Mamtani R, Boursi B. Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study. J Clin Psychiatry. 2015; 76(11): 1522–8. Epub 2015/ 11/19. https://doi.org/10.4088/JCP.15m09961 PMID: 26580313.
17. Bruch JD. Intestinal infection associated with future onset of an anxiety disorder: Results of a nationally representative study. Brain Behav Immun. 2016; 57: 222–6. Epub 2016/05/26. https://doi.org/10.1016/j.bbi.2016.05.014 PMID: 27223096.
18. Goehler LE, Park SM, Opitz N, Lyte M, Gaykema RP. Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav Immun. 2008; 22(3): 354–66. Epub 2007/10/09. https://doi.org/10.1016/j.bbi.2007.08.009 PMID: 17920243; PubMed Central PMCID: PMCPMC2259293.
19. Lyte M, Varcoe JJ, Bailey MT. Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiol Behav. 1998; 65(1): 63–8. Epub 1998/11/12. PMID: 9811366.
20. Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World J Gastroenterol. 2015; 21(10): 3072–84. Epub 2015/03/18. https://doi.org/10.3748/wjg.v21.i10.3072 PMID: 25780308; PubMed Central PMCID: PMCPMC4356930.
21. Ganji-Arjenaki M, Rafieian-Kopaei M. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review. J Cell Physiol. 2017. Epub 2017/03/16. https://doi.org/10.1002/jcp.25911 PMID: 28294322.
22. Mantegazza C, Molinari P, D’Auria E, Sonnino M, Morelli L, Zuccotti GV. Probiotics and antibiotic-associated diarrhea in children: A review and new evidence on Lactobacillus rhamnosus GG during and after antibiotic treatment. Pharmacol Res. 2017. Epub 2017/08/23. https://doi.org/10.1016/j.phrs.2017.08.001 PMID: 28827186.
23. Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B, et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology. 2013; 144(7): 1394–401, 401.e1-4. Epub 2013/03/12. https://doi.org/10.1053/j.gastro.2013.02.043 PMID: 23474283; PubMed Central PMCID: PMCPMC3839572.
24. Benton D, Williams C, Brown A. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr. 2007; 61(3): 355–61. Epub 2006/12/08. https://doi.org/10.1038/sj.ejcn. 1602546 PMID: 17151594.
25. Ait-Belgnaoui A, Durand H, Cartier C, Chaumaz G, Eutamene H, Ferrier L, et al. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology. 2012; 37(11): 1885–95. Epub 2012/05/01. https://doi.org/10.1016/j.psyneuen.2012.03.024 PMID: 22541937.
26. Ait-Belgnaoui A, Colom A, Braniste V, Ramalho L, Marrot A, Cartier C, et al. Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice. Neurogastroenterol Motil. 2014; 26(4): 510–20. Epub 2014/01/01. https://doi.org/10.1111/nmo.12295 PMID: 24372793.
27. Pirbaglou M, Katz J, de Souza RJ, Stearns JC, Motamed M, Ritvo P. Probiotic supplementation can positively affect anxiety and depressive symptoms: a systematic review of randomized controlled trials. Nutr Res. 2016; 36(9): 889–98. Epub 2016/09/17. https://doi.org/10.1016/j.nutres.2016.06.009PMID: 27632908.
28. Romijn AR, Rucklidge JJ. Systematic review of evidence to support the theory of psychobiotics. Nutr Rev. 2015; 73(10): 675–93. Epub 2015/09/16. https://doi.org/10.1093/nutrit/nuv025 PMID: 26370263.
29. Wang H, Lee IS, Braun C, Enck P. Effect of Probiotics on Central Nervous System Functions in Animals and Humans: A Systematic Review. J Neurogastroenterol Motil. 2016; 22(4): 589–605. Epub 2016/07/15. https://doi.org/10.5056/jnm16018 PMID: 27413138; PubMed Central PMCID: PMCPMC5056568.
30. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009; 6(7): e1000100. Epub 2009/07/22. https://doi.org/10.1371/journal.pmed.1000100 PMID: 19621070; PubMed Central PMCID: PMCPMC2707010.
31. Vesterinen HM, Sena ES, Egan KJ, Hirst TC, Churolov L, Currie GL, et al. Meta-analysis of data from animal studies: a practical guide. J Neurosci Methods. 2014; 221: 92–102. Epub 2013/10/09. https://doi.org/10.1016/j.jneumeth.2013.09.010 PMID: 24099992.
32. Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol. 2014; 14: 43. Epub 2014/03/29. https://doi.org/10.1186/1471-2288-14-43 PMID: 24667063; PubMed Central PMCID: PMCPMC4230647.
33. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011; 343: d5928. Epub 2011/10/20. https://doi.org/10.1136/bmj.d5928 PMID: 22008217; PubMed Central PMCID: PMCPMC3196245.
34. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011; 105(5): 755–64. Epub 2010/10/27. https://doi.org/10.1017/S0007114510004319 PMID: 20974015.
35. Cochrane Handbook for Systematic Reviews of Interventions: The Cochrane Collaboration; 2011. Available from: http://training.cochrane.org/handbook.
36. Rohatgi A. WebPlotDigitizer 2017. Available from: http://arohatgi.info/WebPlotDigitizer.
37. Guyot P, Ades AE, Ouwens MJ, Welton NJ. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2012; 12: 9. Epub 2012/02/03. https://doi.org/10.1186/1471-2288-12-9 PMID: 22297116; PubMed Central PMCID: PMCPMC3313891.
38. Tsafnat G, Glasziou P, Choong MK, Dunn A, Galgani F, Coiera E. Systematic review automation technologies. Syst Rev. 2014; 3: 74. Epub 2014/07/10. https://doi.org/10.1186/2046-4053-3-74 PMID: 25005128; PubMed Central PMCID: PMCPMC4100748.
39. R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2016.
40. Tipton E. Small sample adjustments for robust variance estimation with meta-regression. Psychol Methods. 2015; 20(3): 375–93. Epub 2014/04/30. https://doi.org/10.1037/met0000011 PMID: 24773356.
41. Kelly JR, Allen AP, Temko A, Hutch W, Kennedy PJ, Farid N, et al. Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects. Brain Behavior and Immunity. 2017; 61: 50–9. https://doi.org/10.1016/j.bbi.2016.11.018 PubMed PMID: WOS:000395365900008. PMID: 27865949
42. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414): 557–60. Epub 2003/09/06. https://doi.org/10.1136/bmj.327.7414.557 PMID: 12958120; PubMed Central PMCID: PMCPMC192859.
43. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109): 629–34. Epub 1997/10/06. PMID: 9310563; PubMed Central PMCID: PMCPMC2127453.
44. Agusti A, Moya-Perez A, Campillo I, Montserrat-de la Paz S, Cerrudo V, Perez-Villalba A, et al. Bifidobacterium pseudocatenulatum CECT 7765 ameliorates neuroendocrine alterations associated with an exaggerated stress response and anhedonia in obese mice. Mol Neurobiol. 2017. Epub 2017/09/19. https://doi.org/10.1007/s12035-017-0768-z PMID: 28921462.
45. Barrera-Bugueno C, Realini O, Escobar-Luna J, Sotomayor-Zarate R, Gotteland M, Julio-Pieper M, et al. Anxiogenic effects of a Lactobacillus, inulin and the synbiotic on healthy juvenile rats. Neuroscience. 2017; 359: 18–29. Epub 2017/07/12. https://doi.org/10.1016/j.neuroscience.2017.06.064 PMID: 28694176.
46. Beilharz JE, Kaakoush NO, Maniam J, Morris MJ. Cafeteria diet and probiotic therapy: cross talk among memory, neuroplasticity, serotonin receptors and gut microbiota in the rat. Mol Psychiatry. 2017. Epub 2017/03/16. https://doi.org/10.1038/mp.2017.38 PMID: 28289278.
47. Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil. 2011; 23(12): 1132–9. Epub 2011/10/13. https://doi.org/10.1111/j.1365-2982.2011.01796.x PMID: 21988661; PubMed Central PMCID: PMCPmc3413724.
48. Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology. 2010; 139(6): 2102–12.e1. Epub 2010/07/06. https://doi.org/10.1053/j.gastro.2010.06.063 PMID: 20600016.
49. Bharwani A, Mian MF, Surette MG, Bienenstock J, Forsythe P. Oral treatment with Lactobacillus rhamnosus attenuates behavioural deficits and immune changes in chronic social stress. BMC Med. 2017; 15(1): 7. Epub 2017/01/12. https://doi.org/10.1186/s12916-016-0771-7 PMID: 28073366; PubMed Central PMCID: PMCPMC5225647.
50. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011; 108(38): 16050–5. Epub 2011/08/31. https://doi.org/10.1073/pnas.1102999108 PMID: 21876150; PubMed Central PMCID: PMCPmc3179073.
51. Cowan CS, Callaghan BL, Richardson R. The effects of a probiotic formulation (Lactobacillus rhamnosus and L. helveticus) on developmental trajectories of emotional learning in stressed infant rats. Transl Psychiatry. 2016; 6(5): e823. Epub 2016/06/01. https://doi.org/10.1038/tp.2016.94 PMID: 27244232.
52. Divyashri G, Krishna G, Muralidhara, Prapulla SG. Probiotic attributes, antioxidant, anti-inflammatory and neuromodulatory effects of Enterococcus faecium CFR 3003: In vitro and in vivo evidence. J Med Microbiol. 2015; 64(12): 1527–40. Epub 2015/10/10. https://doi.org/10.1099/jmm.0.000184 PMID: 26450608.
53. Emge JR, Huynh K, Miller EN, Kaur M, Reardon C, Barrett KE, et al. Modulation of the microbiota-gut-brain axis by probiotics in a murine model of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol. 2016; 310(11): G989–98. Epub 2016/04/09. https://doi.org/10.1152/ajpgi.00086.2016PMID: 27056723.
54. Jang HM, Jang SE, Han MJ, Kim DH. Anxiolytic-like effect of Bifidobacterium adolescentis IM38 in mice with or without immobilisation stress. Benef Microbes. 2017: 1–10. Epub 2017/10/04. https://doi.org/10.3920/bm2016.0226 PMID: 28969445.
55. Liang S, Wang T, Hu X, Luo J, Li W, Wu X, et al. Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience. 2015; 310: 561–77. Epub 2015/09/27. https://doi.org/10.1016/j.neuroscience.2015.09.033PMID: 26408987.
56. Liu WH, Chuang HL, Huang YT, Wu CC, Chou GT, Wang S, et al. Alteration of behavior and mono-amine levels attributable to Lactobacillus plantarum PS128 in germ-free mice. Behav Brain Res. 2016; 298(Pt B): 202–9. Epub 2015/11/03. https://doi.org/10.1016/j.bbr.2015.10.046 PMID: 26522841.
57. Liu YW, Liu WH, Wu CC, Juan YC, Wu YC, Tsai HP, et al. Psychotropic effects of Lactobacillus plantarum PS128 in early life-stressed and naive adult mice. Brain Res. 2016; 1631: 1–12. Epub 2015/12/ 02. https://doi.org/10.1016/j.brainres.2015.11.018 PMID: 26620542.
58. Luo J, Wang T, Liang S, Hu X, Li W, Jin F. Ingestion of Lactobacillus strain reduces anxiety and improves cognitive function in the hyperammonemia rat. Sci China Life Sci. 2014; 57(3): 327–35. Epub 2014/02/21. https://doi.org/10.1007/s11427-014-4615-4 PMID: 24554471.
59. Mackos AR, Eubank TD, Parry NM, Bailey MT. Probiotic Lactobacillus reuteri attenuates the stressor-enhanced severity of Citrobacter rodentium infection. Infect Immun. 2013; 81(9): 3253–63. Epub 2013/06/27. https://doi.org/10.1128/IAI.00278-13 PMID: 23798531; PubMed Central PMCID: PMCPMC3754198.
60. Matthews DM, Jenks SM. Ingestion of Mycobacterium vaccae decreases anxiety-related behavior and improves learning in mice. Behav Processes. 2013; 96: 27–35. Epub 2013/03/05. https://doi.org/10.1016/j.beproc.2013.02.007 PMID: 23454729.
61. McKernan DP, Fitzgerald P, Dinan TG, Cryan JF. The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol Motil. 2010; 22(9): 1029–35, e268. Epub 2010/06/04. https://doi.org/10.1111/j.1365-2982.2010.01520.x PMID: 20518856.
62. Moya-Perez A, Perez-Villalba A, Benitez-Paez A, Campillo I, Sanz Y. Bifidobacterium CECT 7765 modulates early stress-induced immune, neuroendocrine and behavioral alterations in mice. Brain Behav Immun. 2017; 65: 43–56. Epub 2017/05/18. https://doi.org/10.1016/j.bbi.2017.05.011 PMID: 28512033.
63. Smith CJ, Emge JR, Berzins K, Lung L, Khamishon R, Shah P, et al. Probiotics normalize the gut-brain-microbiota axis in immunodeficient mice. Am J Physiol Gastrointest Liver Physiol. 2014; 307(8): G793–802. Epub 2014/09/06. https://doi.org/10.1152/ajpgi.00238.2014 PMID: 25190473; PubMed Central PMCID: PMCPMC4200314.
64. Vanhaecke T, Aubert P, Grohard PA, Durand T, Hulin P, Paul-Gilloteaux P, et al. L. fermentum CECT 5716 prevents stress-induced intestinal barrier dysfunction in newborn rats. Neurogastroenterol Motil. 2017. Epub 2017/04/04. https://doi.org/10.1111/nmo.13069 PMID: 28370715.
65. Wang T, Hu X, Liang S, Li W, Wu X, Wang L, et al. Lactobacillus fermentum NS9 restores the antibiotic induced physiological and psychological abnormalities in rats. Benef Microbes. 2015; 6(5): 707–17. Epub 2015/04/15. https://doi.org/10.3920/BM2014.0177 PMID: 25869281.
66. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011; 343: d4002. Epub 2011/07/26. https://doi.org/10.1136/bmj.d4002 PMID: 21784880.
67. Moja L, Pecoraro V, Ciccolallo L, Dall’Olmo L, Virgili G, Garattini S. Flaws in animal studies exploring statins and impact on meta-analysis. Eur J Clin Invest. 2014; 44(6): 597–612. Epub 2014/03/29. https://doi.org/10.1111/eci.12264 PMID: 24665945.
68. Kato-Kataoka A, Nishida K, Takada M, Kawai M, Kikuchi-Hayakawa H, Suda K, et al. Fermented Milk Containing Lactobacillus casei Strain Shirota Preserves the Diversity of the Gut Microbiota and Relieves Abdominal Dysfunction in Healthy Medical Students Exposed to Academic Stress. Appl Environ Microbiol. 2016; 82(12): 3649–58. https://doi.org/10.1128/AEM.04134-15 PubMed PMID: WOS:000377018400023. PMID: 27208120
69. Lorenzo-Zuniga V, Llop E, Suarez C, Alvarez B, Abreu L, Espadaler J, et al. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World J Gastroenterol. 2014; 20 (26): 8709–16. Epub 2014/07/16. https://doi.org/10.3748/wjg.v20.i26.8709 PMID: 25024629; PubMed Central PMCID: PMCPMC4093724.
70. Lyra A, Hillila M, Huttunen T, Mannikko S, Taalikka M, Tennila J, et al. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo. World J Gastroenterol. 2016; 22(48): 10631–42. Epub 2017/01/14. https://doi.org/10.3748/wjg.v22.i48.10631 PMID: 28082816; PubMed Central PMCID: PMCPMC5192275.
71. Marcos A, Warnberg J, Nova E, Gomez S, Alvarez A, Alvarez R, et al. The effect of milk fermented by yogurt cultures plus Lactobacillus casei DN-114001 on the immune response of subjects under academic examination stress. Eur J Nutr. 2004; 43(6): 381–9. Epub 2004/08/17. https://doi.org/10.1007/ s00394-004-0517-8 PMID: 15309418.
72. Pinto-Sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, et al. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. Gastroenterology. 2017; 153(2): 448–59.e8. Epub 2017/05/10. https://doi.org/10.1053/j.gastro.2017.05.003 PMID: 28483500.
73. Romijn AR, Rucklidge JJ, Kuijer RG, Frampton C. A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression. Aust N Z J Psychiatry. 2017: 4867416686694. Epub 2017/01/11. https://doi.org/10.1177/0004867416686694PMID: 28068788.
74. Simren M, Ohman L, Olsson J, Svensson U, Ohlson K, Posserud I, et al. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome—a randomized, double-blind, controlled study. Aliment Pharmacol Ther. 2010; 31(2): 218–27. https://doi.org/10.1111/j.1365-2036.2009.04183.x PubMed PMID: WOS:000272864600005. PMID: 19863495
75. Slykerman RF, Hood F, Wickens K, Thompson JMD, Barthow C, Murphy R, et al. Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Rando-mised Double-blind Placebo-controlled Trial. EBioMedicine. 2017; 24: 159–65. Epub 2017/09/26. https://doi.org/10.1016/j.ebiom.2017.09.013 PMID: 28943228; PubMed Central PMCID: PMCPMC5652021.
76. Steenbergen L, Sellaro R, van Hemert S, Bosch JA, Colzato LS. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun. 2015. Epub 2015/04/12. https://doi.org/10.1016/j.bbi.2015.04.003 PMID: 25862297.
77. Takada M, Nishida K, Gondo Y, Kikuchi-Hayakawa H, Ishikawa H, Suda K, et al. Beneficial effects of Lactobacillus casei strain Shirota on academic stress-induced sleep disturbance in healthy adults: a double-blind, randomised, placebo-controlled trial. Benef Microbes. 2017; 8(2): 153–62. Epub 2017/ 04/27. https://doi.org/10.3920/BM2016.0150 PMID: 28443383.
78. Takada M, Nishida K, Kataoka-Kato A, Gondo Y, Ishikawa H, Suda K, et al. Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models. Neurogastroenterology and Motility. 2016; 28(7): 1027–36. https://doi.org/10.1111/nmo.12804 PubMed PMID: WOS:000383290800008. PMID: 26896291
79. Yang H, Zhao X, Tang S, Huang H, Zhao X, Ning Z, et al. Probiotics reduce psychological stress in patients before laryngeal cancer surgery. Asia Pac J Clin Oncol. 2016; 12(1): e92–6. Epub 2014/02/ 28. https://doi.org/10.1111/ajco.12120 PMID: 24571169.
80. Harmer CJ, Cowen PJ.’It’s the way that you look at it’—a cognitive neuropsychological account of SSRI action in depression. Philos Trans R Soc Lond B Biol Sci. 2013; 368(1615): 20120407. Epub 2013/02/27. https://doi.org/10.1098/rstb.2012.0407 PMID: 23440467; PubMed Central PMCID: PMCPMC3638386.
81. Segers ME, Lebeer S. Towards a better understanding of Lactobacillus rhamnosus GG—host interactions. Microb Cell Fact. 2014; 13 Suppl 1: S7. Epub 2014/09/05. https://doi.org/10.1186/1475-2859-13-s1-s7 PMID: 25186587; PubMed Central PMCID: PMCPMC4155824.
82. Didari T, Solki S, Mozaffari S, Nikfar S, Abdollahi M. A systematic review of the safety of probiotics. Expert Opin Drug Saf. 2014; 13(2): 227–39. Epub 2014/01/11. https://doi.org/10.1517/14740338.2014.872627 PMID: 24405164.
83. Ibnou-Zekri N, Blum S, Schiffrin EJ, von der Weid T. Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun. 2003; 71(1): 428–36. Epub 2002/12/24. https://doi.org/10.1128/IAI.71.1.428-436.2003 PMID: 12496193; PubMed Central PMCID: PMCPMC143181.
84. Wells JM. Immunomodulatory mechanisms of lactobacilli. Microb Cell Fact. 2011; 10 Suppl 1: S17. Epub 2011/10/26. https://doi.org/10.1186/1475-2859-10-s1-s17 PMID: 21995674; PubMed Central PMCID: PMCPMC3231924.
85. Lamouse-Smith ES, Tzeng A, Starnbach MN. The intestinal flora is required to support antibody responses to systemic immunization in infant and germ free mice. PLoS One. 2011; 6(11): e27662. Epub 2011/11/25. https://doi.org/10.1371/journal.pone.0027662 PMID: 22114681; PubMed Central PMCID: PMCPMC3219679.
86. Shapiro JM, Cho JH, Sands BE, LeLeiko NS. Bridging the gap between host immune response and intestinal dysbiosis in inflammatory bowel disease: does immunoglobulin A mark the spot? Clin Gastroenterol Hepatol. 2015; 13(5): 842–6. Epub 2015/03/01. https://doi.org/10.1016/j.cgh.2015.02.028PMID: 25725444.
87. Forsythe P, Kunze WA, Bienenstock J. On communication between gut microbes and the brain. Curr Opin Gastroenterol. 2012; 28(6): 557–62. Epub 2012/09/27. https://doi.org/10.1097/MOG. 0b013e3283572ffa PMID: 23010679.
88. Bebarta V, Luyten D, Heard K. Emergency medicine animal research: Does use of randomization and blinding affect the results? Acad Emerg Med. 2003; 10(6): 684–7. Epub 2003/06/05. PMID: 12782533.
89. Crossley NA, Sena E, Goehler J, Horn J, van der Worp B, Bath PM, et al. Empirical evidence of bias in the design of experimental stroke studies: A metaepidemiologic approach. Stroke. 2008; 39(3): 929–34. Epub 2008/02/02. https://doi.org/10.1161/STROKEAHA.107.498725 PMID: 18239164.
90. Hirst JA, Howick J, Aronson JK, Roberts N, Perera R, Koshiaris C, et al. The need for randomization in animal trials: an overview of systematic reviews. PLoS One. 2014; 9(6): e98856. Epub 2014/06/07. https://doi.org/10.1371/journal.pone.0098856 PMID: 24906117; PubMed Central PMCID: PMCPMC4048216.
91. Macleod MR, Lawson McLean A, Kyriakopoulou A, Serghiou S, de Wilde A, Sherratt N, et al. Risk of Bias in Reports of In Vivo Research: A Focus for Improvement. PLoS Biol. 2015; 13(10): e1002273. Epub 2015/10/16. https://doi.org/10.1371/journal.pbio.1002273 PMID: 26460723; PubMed Central PMCID: PMCPMC4603955.
92. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012; 489(7415): 220–30. Epub 2012/09/14. https://doi.org/10.1038/nature11550 PMID: 22972295; PubMed Central PMCID: PMCPMC3577372.
93. Bogovic Matijasic B, Obermajer T, Lipoglavsek L, Sernel T, Locatelli I, Kos M, et al. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial. J Dairy Sci. 2016; 99(7): 5008–21. Epub 2016/05/10. https://doi.org/10.3168/jds. 2015-10743 PMID: 27157575.
94. McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, Goodman AL, et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med. 2011; 3(106): 106ra. Epub 2011/10/28. https://doi.org/10.1126/scitranslmed.3002701PMID: 22030749; PubMed Central PMCID: PMCPMC3303609.
95. Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Backhed HK, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012; 150(3): 470–80. Epub 2012/08/ 07. https://doi.org/10.1016/j.cell.2012.07.008 PMID: 22863002; PubMed Central PMCID: PMCPMC3505857.
96. DiGiulio DB, Callahan BJ, McMurdie PJ, Costello EK, Lyell DJ, Robaczewska A, et al. Temporal and spatial variation of the human microbiota during pregnancy. Proc Natl Acad Sci U S A. 2015; 112(35): 11060–5. Epub 2015/08/19. https://doi.org/10.1073/pnas.1502875112 PMID: 26283357; PubMed Central PMCID: PMCPMC4568272.
97. Labus JS, Bolus R, Chang L, Wiklund I, Naesdal J, Mayer EA, et al. The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther. 2004; 20(1): 89–97. Epub 2004/07/01. https://doi.org/10.1111/j.1365-2036.2004.02007.x PMID: 15225175.
98. Jerndal P, Ringstrom G, Agerforz P, Karpefors M, Akkermans LM, Bayati A, et al. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS. Neurogastroenterol Motil. 2010; 22(6): 646–e179. Epub 2010/04/07. https://doi.org/10.1111/j.1365-2982.2010.01493.x PMID: 20367800.
99. Melsen WG, Bootsma MC, Rovers MM, Bonten MJ. The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses. Clin Microbiol Infect. 2014; 20(2): 123–9. Epub 2013/12/11. https://doi.org/10.1111/1469-0691.12494 PMID: 24320992.
100. Button KS, Ioannidis JP, Mokrysz C, Nosek BA, Flint J, Robinson ES, et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013; 14(5): 365–76. Epub 2013/04/11. https://doi.org/10.1038/nrn3475 PMID: 23571845.